Physician profile
Margaret Park
NPI 1396754735
$245,270.29
in general payments reported to CMS, 2019-2025
11 companies · $44K in 2025
The $44K reported for 2025 was more than what 96% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.79 · 2020: $48K · 2021: $25K · 2022: $16K · 2023: $59K · 2024: $53K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $102K · Honoraria: $22K · Travel and Lodging: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,250 · Food and Beverage: $2,698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $101,867.50 |
| Honoraria | $22,438.00 |
| Travel and Lodging | $13,583.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,624.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,250.00 |
| Food and Beverage | $2,698.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $109,605.74 | 2023-2025 | Sunosi |
| Harmony Biosciences LLC | $83,683.61 | 2020-2025 | Wakix |
| Eisai INC. | $23,567.39 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $12,991.79 | 2019-2025 | |
| Tonix Medicines, INC. | $7,809.29 | 2025 | |
| Avadel Cns Pharmaceuticals, LLC | $7,242.98 | 2024-2025 | Lumryz |
| Janssen Pharmaceuticals, INC | $154.19 | 2023 | Xarelto |
| Inspire Medical Systems, INC. | $150.03 | 2023 | Inspire |
| Glaxosmithkline, LLC. | $26.91 | 2021 | |
| Noctrix Health, INC. | $20.09 | 2025 | Nidra |
| Lilly USA, LLC | $18.27 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.